Results 181 to 190 of about 7,946 (266)

Comparative Analyses of Antiviral Potencies of Second-Generation Integrase Strand Transfer Inhibitors (INSTIs) and the Developmental Compound 4d Against a Panel of Integrase Quadruple Mutants. [PDF]

Viruses
Smith SJ, Zhao XZ, Hughes SH, Burke TR.
europepmc   +1 more source

Patients reported neuropsychiatric adverse events and associated factors among PLHIV patients receiving DTG-based regimen antiretroviral therapy real-life clinical practice in Ethiopia: multi center crossetional study. [PDF]

BMC Psychiatry
Chanie GS, Belachew EA, Seid AM, Limenh LW, Mitku ML, Beyna AT, Mengesha AK, Melese M, Esubalew D, Gela YY, Ayenew W, Simegn W.   +11 more
europepmc   +1 more source

New and efficient synthesis of 1,4-oxazines through the reaction of acetylenic esters and nitrosonaphthols in the presence of phosphine derivatives

ARKIVOC, 2016
Razieh Mohebat, Afshin Yazdani Elah Abadi, Aliakbar Soltani, Mitra Saghafi   +3 more
doaj   +1 more source

Investigations on the synthesis of new photochromic oxazine derivatives [PDF]

, 2000
Pritchard, Martin David
core  

Greener, Simple and Efficient Synthesis of Some Oxazine-2-amine Derivatives by Preheated Fly-Ash Catalyzed Cyclization of Aryl Chalcones under Solvent-Free Conditions

, 2014
G. Thirunarayanan
openalex   +1 more source

SERS Detection of Hydrophobic Molecules: Thio-β-Cyclodextrin-Driven Rapid Self-Assembly of Uniform Silver Nanoparticle Monolayers and Analyte Trapping. [PDF]

Biosensors (Basel)
Yuan Q, Wang Y.
europepmc   +1 more source

Advancing single-molecule fluorescence spectroscopy and super-resolution microscopy with organic fluorophores [PDF]

, 2009
Vogelsang, Jan
core  

Antihypoxic Activity of 6-Aryl-4-hydroxy-5,6-dihydro-4h-1,3-oxAzines

, 2014
С. С. Зыкова
openalex   +1 more source

A United States HIV provider survey of antiretroviral therapy management in people living with HIV with co-occurring conditions. [PDF]

AIDS Res Ther
Krishnan S, Rivera MBM, Lippincott CK, Shah M.   +3 more
europepmc   +1 more source

24-month outcomes after switching to Dolutegravir/Lamivudine in people living with HIV and HBcAb positivity at the Beijing Ditan Hospital in China. [PDF]

Ann Med
Fu J, Biao R, Liu Y, Chen J, Zhao H.
europepmc   +1 more source